EMA Risk Management Virtual Information Day

Registered participants find access to the virtual conference in their DIA account. This virtual information day provides an update of ongoing Agency’s activities on medicines’ risk management.

Back to Agenda

Session 1

Speaker(s)

GVP Module Product – or Population-Specific Considerations III: Pregnant and Breastfeeding Women – Where We Are

Viola Macolic Sarinic, DrSc, MD, MSc

European Medicines Agency, Netherlands

Scientific Officer

COVID-19 Pandemic – Challenges and Lessons Learned

Ulla Wändel Liminga, DrMed, MS, RPh

Medical Products Agency (MPA), Sweden

Scientific Director Pharmacology/Toxicology

EMA Pregnancy Strategy

Corinne de Vries, PhD, MA, MSc

European Medicines Agency, Netherlands

EMA liaison official to the US FDA

IMI Conception Consortium: Optimising Data Collection in Pregnant and Breastfeeding Women

David John Lewis, PhD

Novartis Pharma Gmbh, Switzerland

Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance

Have an account?